Pharmaceutical

Tevogen Bio partners Microsoft for HPV treatment

Tevogen Bio’s AI effort Tevogen.AI has partnered with Microsoft to advance the development of an HPV specific CTL treatment.

Nov 7, 2024 - 06:00
Tevogen Bio partners Microsoft for HPV treatment
Tevogen Bio’s AI effort Tevogen.AI has partnered with Microsoft to advance the development of an HPV specific CTL treatment.
Read the original article

Tags:

Previous Article

GSK CEO addresses declining trust in vaccines following Trump re-election

Next Article

Trump triumphs but impact on healthcare industry remains unclear

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

New 2023 guidelines for the management of cardiomyopathies

New 2023 guidelines for the management of cardiomyopathies

Sep 5, 2023

J&J seeks label expansion for Tremfya in ulcerative colitis

J&J seeks label expansion for Tremfya in ulcerative col...

Mar 13, 2024

M&A revival with a 71% increase in billion-dollar transactions in Q1 2024

M&A revival with a 71% increase in billion-dollar trans...

May 3, 2024